Wikipedia -WSS

Wikipedia

author：explore 2025-09-06 04:38:10 - browse：387

Stock exchange — Drew Angerer/Getty Images

Structure Therapeutics reported Monday that its oral GLP-1 drug led to weight loss in two small studies, leading shares to surge in pre-market trading.

In a 12-week Phase 2a study, the daily pill in a capsule formulation led to 6.2% placebo-adjusted weight loss. In a separate 12-week pharmacokinetics study, the company tested a new tablet formulation of the drug, called GSBR-1290, and it led to placebo-adjusted weight loss of up to 6.9%.

Though it’s difficult to compare across different studies, the results appear to approach the levels of weight loss seen at 12 weeks in a separate Phase 2 study of Eli Lilly’s GLP-1 pill called orforglipron. That entire study lasted 36 weeks, but at 12 weeks, participants had about 6%-7% placebo-adjusted weight loss.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： EF3 tornado rips through North Carolina amid extreme weather nationwide

focus

WSS

UCSF medical school apologizes for unethical prisoner experiments

Winning ticket for $1 billion Powerball jackpot sold in California

Senate panel clears PBM, hopsital reforms

Indian pharmaceutical industry in denial over drug

Ambulance rides for just $100? Advisers want major billing fixes

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Wikipedia

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

Bright Health sells Medicare Advantage business to Molina

Winning ticket for $1 billion Powerball jackpot sold in California

Activists slam private health insurers over coverage restrictions

Study: New antibiotic targets gonorrhea as well as last existing drug

DIEP, the 'gold standard' of breast reconstruction, is under threat

A clever new way to fix Medicaid and graduate medical education

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Biotech incubator Curie.Bio graduates its first startup

Medical leaders decry Supreme Court decision on affirmative action

White House calls on federal agencies to crack down on AI abuses

focus

Hospitals struggle to profit from CAR

Medicare solvency divides Republicans at the presidential debate

Victims of gun violence feel impacts long after bullet wound

7 more heat

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

White House calls on federal agencies to crack down on AI abuses

knowledge

focus

focus

leisure time